Kimberly-Clark Corporation (KMB)vsNu Skin Enterprises Inc (NUS)
KMB
Kimberly-Clark Corporation
$109.98
-0.33%
CONSUMER DEFENSIVE · Cap: $36.70B
NUS
Nu Skin Enterprises Inc
$4.79
-1.03%
CONSUMER DEFENSIVE · Cap: $230.73M
Smart Verdict
WallStSmart Research — data-driven comparison
Kimberly-Clark Corporation generates 1106% more annual revenue ($16.58B vs $1.38B). KMB leads profitability with a 11.8% profit margin vs -15.7%. NUS appears more attractively valued with a PEG of 0.78. KMB earns a higher WallStSmart Score of 52/100 (C-).
KMB
Buy52
out of 100
Grade: C-
NUS
Hold47
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-35.6%
Fair Value
$79.34
Current Price
$109.98
$30.64 premium
Margin of Safety
+53.3%
Fair Value
$21.79
Current Price
$4.79
$17.00 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 112 in profit
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
0.6% revenue growth
Weak financial health signals
Trading at 20.9x book value
Smaller company, higher risk/reward
ROE of 6.9% — below average capital efficiency
Revenue declined 17.1%
Earnings declined 98.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : KMB
The strongest argument for KMB centers on Return on Equity.
Bull Case : NUS
The strongest argument for NUS centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bear Case : KMB
The primary concerns for KMB are PEG Ratio, Revenue Growth, Piotroski F-Score. Debt-to-equity of 3.72 is elevated, increasing financial risk.
Bear Case : NUS
The primary concerns for NUS are Market Cap, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
KMB profiles as a value stock while NUS is a turnaround play — different risk/reward profiles.
NUS carries more volatility with a beta of 0.97 — expect wider price swings.
KMB is growing revenue faster at 0.6% — sustainability is the question.
KMB generates stronger free cash flow (556M), providing more financial flexibility.
Bottom Line
KMB scores higher overall (52/100 vs 47/100). NUS offers better value entry with a 53.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Kimberly-Clark Corporation
CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA
Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Visit Website →Nu Skin Enterprises Inc
CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA
Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.
Visit Website →Compare with Other HOUSEHOLD & PERSONAL PRODUCTS Stocks
Want to dig deeper into these stocks?